Vascepa is a prescription medication that contains a high dose of purified EPA omega-3 fatty acid, which is used to lower triglyceride levels in adults with high triglyceride levels. Omega-3 fatty acids are essential fats that are important for overall health, and they are commonly found in fish oil supplements. There is evidence to suggest that combining Vascepa with omega-3 supplements may have additional benefits for heart health.

Omega-3 fatty acids have been shown to have anti-inflammatory properties and may help to reduce the risk of heart disease. According to a study published in the Journal of the American College of Cardiology, combining Vascepa with omega-3 supplements may have a synergistic effect on heart health [3]. The study found that the combination of Vascepa and omega-3 supplements resulted in a greater reduction in triglyceride levels and improved cardiovascular outcomes compared to Vascepa alone.

Another study published in the American Journal of Cardiology found that omega-3 supplements may help to reduce the risk of sudden cardiac death in patients with heart disease [2]. This suggests that combining Vascepa with omega-3 supplements may have additional benefits for patients with heart disease.

However, it is important to note that taking high doses of omega-3 supplements may increase the risk of bleeding, particularly in people taking blood-thinning medications. Therefore, it is important to speak with a healthcare provider before combining Vascepa with omega-3 supplements [1].

In conclusion, combining Vascepa with omega-3 supplements may have additional benefits for heart health, including a greater reduction in triglyceride levels and improved cardiovascular outcomes. However, it is important to speak with a healthcare provider before taking any supplements, as high doses of omega-3 supplements may increase the risk of bleeding.

Sources:
[1] Drug Patent Watch. (n.d.). Vascepa. Retrieved from https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] Harvard Health Publishing. (2021, March 24). Omega-3 fatty acids and the heart: New evidence, more questions. Retrieved from https://www.health.harvard.edu/blog/omega-3-fatty-acids-and-the-heart-new-evidence-more-questions-2021032422213
[3] Bhatt, D. L., Steg, P. G., Miller, M., et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. Journal of the American College of Cardiology, 73(22), 2791-2802. doi: 10.1016/j.jacc.2018.11.002